Literature DB >> 22183303

The association between the mannose-binding lectin codon 54 polymorphism and systemic lupus erythematosus: a meta-analysis update.

Young Ho Lee1, Hye-Soon Lee, Sung Jae Choi, Jong Dae Ji, Gwan Gyu Song.   

Abstract

The aim of this study was to determine whether the functional mannose-binding lectin (MBL2) exon 1 codon 54 polymorphism (rs1800450) confers susceptibility to systemic lupus erythematosus (SLE) in ethnically different populations. A meta-analysis was conducted on the MBL2 codon 54 polymorphism across 21 comparative studies. Meta-analysis showed an association between the MBL2 codon 54 B allele and SLE in all study subjects [odds ratio (OR) = 1.298, 95% confidence interval (CI) = 1.154-1.459, P = 1.4 × 10(-5)]. Analysis after stratification by ethnicity indicated that the MBL2 codon 54 B allele is significantly associated with SLE in Europeans, Asian, and Africans (OR = 1.246, 95% CI = 1.062-1.462, P = 0.007; OR = 1.268, 95% CI = 1.049-1.532, P = 0.014; OR = 1.939, 95% CI = 1.269-2.962, P = 0.002, respectively). However, African Americans had a much lower prevalence of the T allele (5.8%) than any other populations studied, whereas Asians had the highest prevalence (16.2%). This meta-analysis confirms that the MBL2 codon 54 polymorphism is associated with SLE susceptibility in different ethnic groups, and that its prevalence is ethnicity dependent.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22183303     DOI: 10.1007/s11033-011-1361-6

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  33 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Meta-analysis of TNF-alpha promoter -308 A/G polymorphism and SLE susceptibility.

Authors:  Young Ho Lee; John B Harley; Swapan K Nath
Journal:  Eur J Hum Genet       Date:  2006-03       Impact factor: 4.246

3.  Mannose-binding lectin gene polymorphism in Greek systemic lupus erythematosus patients.

Authors:  D Carthy; A Hajeer; B Ollier; K Tarassi; C Papasteriades; K Boki; N Nikolopoulou
Journal:  Br J Rheumatol       Date:  1997-11

Review 4.  Mannan-binding lectin and its role in innate immunity.

Authors:  D C Kilpatrick
Journal:  Transfus Med       Date:  2002-12       Impact factor: 2.019

5.  Analysis of polymorphisms affecting immune complex handling in systemic lupus erythematosus.

Authors:  K E Sullivan; A F Jawad; L M Piliero; N Kim; X Luan; D Goldman; M Petri
Journal:  Rheumatology (Oxford)       Date:  2003-03       Impact factor: 7.580

6.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

7.  Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus.

Authors:  P Garred; H O Madsen; P Halberg; J Petersen; G Kronborg; A Svejgaard; V Andersen; S Jacobsen
Journal:  Arthritis Rheum       Date:  1999-10

8.  [The role of mannose binding lectin in the pathogenesis of systemic lupus erythematosus].

Authors:  Sheng-guang Li; Feng Huang; Xiang-yuan Liu; Xin-xin Deng; Ming Xu; Xian-zi Cong; Yu-zhen Ding; Jun-hua Guo; Xiao-hu Deng; Mian-song Zhao
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2006-02-21

Review 9.  Mannose-binding lectin deficiency--revisited.

Authors:  Peter Garred; Flemming Larsen; Hans O Madsen; Claus Koch
Journal:  Mol Immunol       Date:  2003-09       Impact factor: 4.407

10.  Mannose-binding protein gene polymorphism in systemic lupus erythematosus.

Authors:  E J Davies; N Snowden; M C Hillarby; D Carthy; D M Grennan; W Thomson; W E Ollier
Journal:  Arthritis Rheum       Date:  1995-01
View more
  1 in total

1.  Collectin liver 1 and collectin kidney 1 and other complement-associated pattern recognition molecules in systemic lupus erythematosus.

Authors:  A Troldborg; S Thiel; L Jensen; S Hansen; M J Laska; B Deleuran; J C Jensenius; K Stengaard-Pedersen
Journal:  Clin Exp Immunol       Date:  2015-08-31       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.